When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Adalimumab - Wikipedia

   en.wikipedia.org/wiki/Adalimumab

   The best-selling drugs list published by Genetic Engineering & Biotechnology News, shows that Humira occupied the #1 position for 2015 (US$14.012 billion) and 2016 (US$16.078 billion) [99] From 2012 until the US patent expired in 2016, Humira led the list of top-selling pharmaceutical products, and in 2016, it had US$16 billion of global sales ...

3. TNF inhibitor - Wikipedia

   en.wikipedia.org/wiki/TNF_inhibitor

   A TNF inhibitor is a pharmaceutical drug that suppresses the physiologic response to tumor necrosis factor (TNF), which is part of the inflammatory response.TNF is involved in autoimmune and immune-mediated disorders such as rheumatoid arthritis, ankylosing spondylitis, inflammatory bowel disease, psoriasis, hidradenitis suppurativa and refractory asthma, so TNF inhibitors may be used in their ...

4. List of largest selling pharmaceutical products - Wikipedia

   en.wikipedia.org/wiki/List_of_largest_selling...

   Rank Drug Trade name Type Main indications Company Sales (USD millions/year) ∆ vs 2014 1 Adalimumab: Humira Biologic Rheumatoid arthritis: AbbVie Inc. 14,012 1,469

5. Management of Crohn's disease - Wikipedia

   en.wikipedia.org/wiki/Management_of_Crohn's_disease

   Surgery is normally reserved for complications of Crohn's disease or when disease that resists treatment with drugs is confined to one location that can be removed. [30] Surgery is often used to manage complications of Crohn's disease, including fistulae , small bowel obstruction , colon cancer , small intestine cancer and fibrostenotic ...

6. UnitedHealth to remove AbbVie's Humira from some US drug ...

   www.aol.com/news/unitedhealth-remove-abbvies...

   The U.S. market share for Humira biosimilars stands at nearly 20%, compared with 2.2% in the first quarter of this year, Barclays analysts said in a note on Monday.

7. CVS will remove AbbVie's Humira from some drug ... - AOL

   www.aol.com/news/cvs-remove-abbvies-humira-drug...

   CVS had chosen to keep Humira on the reimbursement list it updated for Jan. 1 2024. Although nine Humira biosimilars were launched the U.S. last year from drugmakers including Amgen, Pfizer and ...